Müller-Newen G - Search Results

1

Intracellular signaling prevents effective blockade of oncogenic gp130 mutants by neutralizing antibodies.

Rinis N, Küster A, Schmitz-Van de Leur H, Mohr A, Müller-Newen G. Rinis N, et al. Cell Commun Signal. 2014 Mar 10;12:14. doi: 10.1186/1478-811X-12-14. Cell Commun Signal. 2014. PMID: 24612692 Free PMC article.

2

Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domain.

Mohr A, Fahrenkamp D, Rinis N, Müller-Newen G. Mohr A, et al. Cell Commun Signal. 2013 Nov 5;11:83. doi: 10.1186/1478-811X-11-83. Cell Commun Signal. 2013. PMID: 24192293 Free PMC article.

3

Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction.

Fahrenkamp D, de Leur HS, Küster A, Chatain N, Müller-Newen G. Fahrenkamp D, et al. Cell Commun Signal. 2015 Feb 15;13:10. doi: 10.1186/s12964-014-0081-7. Cell Commun Signal. 2015. PMID: 25885255 Free PMC article.

4

Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis.

Giese B, Au-Yeung CK, Herrmann A, Diefenbach S, Haan C, Küster A, Wortmann SB, Roderburg C, Heinrich PC, Behrmann I, Müller-Newen G. Giese B, et al. J Biol Chem. 2003 Oct 3;278(40):39205-13. doi: 10.1074/jbc.M303347200. Epub 2003 Jul 23. J Biol Chem. 2003. PMID: 12878601 Free article.

5

A receptor fusion protein for the inhibition of murine oncostatin M.

Brolund L, Küster A, Korr S, Vogt M, Müller-Newen G. Brolund L, et al. BMC Biotechnol. 2011 Jan 11;11:3. doi: 10.1186/1472-6750-11-3. BMC Biotechnol. 2011. PMID: 21223559 Free PMC article.

6

Dynamics and non-canonical aspects of JAK/STAT signalling.

Mohr A, Chatain N, Domoszlai T, Rinis N, Sommerauer M, Vogt M, Müller-Newen G. Mohr A, et al. Eur J Cell Biol. 2012 Jun-Jul;91(6-7):524-32. doi: 10.1016/j.ejcb.2011.09.005. Epub 2011 Oct 21. Eur J Cell Biol. 2012. PMID: 22018664 Review.

7

Consequences of the disease-related L78R mutation for dimerization and activity of STAT3.

Domoszlai T, Martincuks A, Fahrenkamp D, Schmitz-Van de Leur H, Küster A, Müller-Newen G. Domoszlai T, et al. J Cell Sci. 2014 May 1;127(Pt 9):1899-910. doi: 10.1242/jcs.137422. Epub 2014 Feb 25. J Cell Sci. 2014. PMID: 24569879

8

Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery.

Görtz D, Braun GS, Maruta Y, Djudjaj S, van Roeyen CR, Martin IV, Küster A, Schmitz-Van de Leur H, Scheller J, Ostendorf T, Floege J, Müller-Newen G. Görtz D, et al. Sci Rep. 2015 Oct 1;5:14685. doi: 10.1038/srep14685. Sci Rep. 2015. PMID: 26423228 Free PMC article.

9

Dissecting functions of the N-terminal domain and GAS-site recognition in STAT3 nuclear trafficking.

Martincuks A, Fahrenkamp D, Haan S, Herrmann A, Küster A, Müller-Newen G. Martincuks A, et al. Cell Signal. 2016 Aug;28(8):810-25. doi: 10.1016/j.cellsig.2016.03.011. Epub 2016 Mar 31. Cell Signal. 2016. PMID: 27040695

10

Nuclear translocation of STAT3 and NF-κB are independent of each other but NF-κB supports expression and activation of STAT3.

Martincuks A, Andryka K, Küster A, Schmitz-Van de Leur H, Komorowski M, Müller-Newen G. Martincuks A, et al. Cell Signal. 2017 Apr;32:36-47. doi: 10.1016/j.cellsig.2017.01.006. Epub 2017 Jan 9. Cell Signal. 2017. PMID: 28089769

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters